Position in IQV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$383,928
-$668,511 QoQ
Shares Held
1,987
-57.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#697
of 1,077 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $6,325,147 across 7 Diagnostics & Research names. IQV ranks #4 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
2,021 | $2,581,847 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,316 | $2,163,869 | |
| 3 | GH |
Guardant Health, Inc.
|
3,104 | $465,693 | |
| 4 | IQV |
Iqvia Holdings Inc.
This page
|
1,987 | $383,928 | |
| 5 | NTRA |
Natera, Inc.
|
1,338 | $363,200 | |
| 6 | TWST |
Twist Bioscience Corp
|
2,290 | $235,595 | |
| 7 | MYGN |
Myriad Genetics Inc
|
22,945 | $131,015 |
All Filings in IQV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $383,928 | 1,987 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $1,052,439 | 4,669 | Shares | Sole | 2026-02-13 | |
| 2024-12-31 | $1,547,123 | 7,873 | Shares | Sole | 2025-02-06 | |
| 2024-06-30 | $695,426 | 3,289 | Shares | Sole | 2024-08-09 | |
| 2022-09-30 | $556,462 | 3,072 | Shares | Sole | 2022-11-09 | |
| 2020-12-31 | $1,287,694 | 7,187 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,110,823 | 13,391 | Shares | Sole | 2020-11-06 | |
| 2020-03-31 | $694,726 | 6,441 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||